A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Title
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 25, Issue 2, Pages 341-347
Publisher
Springer Nature
Online
2010-12-07
DOI
10.1038/leu.2010.226

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started